Neuroleptic malignant syndrome and its controversies.
Margetić
Branimir
B
Neuropsychiatric Hospital Dr Ivan Barbot, Popovaca, Croatia. branimir.margetic@zg.t-com.hr
Aukst-Margetić
Branka
B
D014150:Antipsychotic Agents / Q000009:adverse effects*; D001569:Benzodiazepines / Q000008:administration & dosage / Q000627:therapeutic use; D002389:Catatonia / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology; D003937:Diagnosis, Differential; D004565:Electroconvulsive Therapy; D006801:Humans; D015994:Incidence; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D018377:Neurotransmitter Agents / Q000378:metabolism; D017891:Pharmacoepidemiology; D020230:Serotonin Syndrome / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology; D013564:Sympathetic Nervous System / Q000187:drug effects
D014150:Antipsychotic Agents; D018377:Neurotransmitter Agents; D001569:Benzodiazepines